Form 4: Health Catalyst CPO Sells Shares for Tax Obligations

Health Catalyst's Chief People Officer, Linda Llewelyn, disposed of 9,762 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Summary

• Linda Llewelyn, Chief People Officer of Health Catalyst, Inc. (HCAT), reported a disposition of common stock.
• The transaction occurred on December 1, 2025, and involved 9,762 shares.
• The shares were disposed of at a price of $2.9002 per share.
• This sale was a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• The transaction was not a discretionary trade by Ms. Llewelyn.
• Following this transaction, Ms. Llewelyn beneficially owns 143,263 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax purposes related to RSU vesting. It is a neutral event that does not indicate a change in management's confidence or the company's financial health.

Positives

• The transaction indicates the vesting of Restricted Stock Units (RSUs) for the Chief People Officer, which is a form of compensation and retention for key management.

Negatives

• The disposition of shares, even for tax purposes, results in a slight reduction in direct insider ownership.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This routine insider transaction, a 'sell to cover' for tax obligations, is common across all industries for executives receiving equity compensation and does not reflect specific industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The impact is minimal as this is a routine, non-discretionary transaction for tax purposes, not an indication of a change in the insider's view of the company's prospects.
• Employees: The vesting of RSUs and subsequent tax-related sale is a standard part of executive compensation packages.

Key Dates

Recommendation

This Form 4 details a routine 'sell to cover' transaction by a corporate officer to satisfy tax obligations upon RSU vesting. Such non-discretionary sales are common and generally do not reflect a change in the officer's investment sentiment or the company's fundamentals. Therefore, it provides no new information to warrant a change in investment recommendation, suggesting a 'hold' position based solely on this filing.

Keywords

Health Catalyst, HCAT, Insider Transaction, Form 4, Restricted Stock Units, RSU, Sell to Cover, Tax Withholding, Linda Llewelyn, Chief People Officer